User profiles for Federico Lavorini
Federico LavoriniConsultant in Respiratory Medicine Careggi University Hospital Verified email at unifi.it Cited by 7522 |
[HTML][HTML] Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
…, P Parronchi, P Fontanari, F Lavorini… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Coronavirus disease 19 (COVID-19) is an emerging infectious disease
caused by SARS-CoV-2. Antiviral immune response is crucial to achieve pathogen clearance; …
caused by SARS-CoV-2. Antiviral immune response is crucial to achieve pathogen clearance; …
[HTML][HTML] Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD
F Lavorini, A Magnan, JC Dubus, T Voshaar… - Respiratory …, 2008 - Elsevier
BACKGROUND: Incorrect usage of inhaler devices might have a major influence on the
clinical effectiveness of the delivered drug. This issue is poorly addressed in management …
clinical effectiveness of the delivered drug. This issue is poorly addressed in management …
[HTML][HTML] Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes
OS Usmani, F Lavorini, J Marshall, WCN Dunlop… - Respiratory …, 2018 - Springer
Background Inhaled drug delivery is the cornerstone treatment for asthma and chronic
obstructive pulmonary disease (COPD). However, use of inhaler devices can be challenging, …
obstructive pulmonary disease (COPD). However, use of inhaler devices can be challenging, …
The first tissue-engineered airway transplantation: 5-year follow-up results
…, MO Jaus, D Barale, S Baiguera, C Comin, F Lavorini… - The Lancet, 2014 - thelancet.com
Background In 2008, the first transplantation of a tissue-engineered trachea in a human
being was done to replace an end-staged left main bronchus with malacia in a 30-year-old …
being was done to replace an end-staged left main bronchus with malacia in a 30-year-old …
Inhaler errors in the CRITIKAL study: type, frequency, and association with asthma outcomes
…, S Henrichsen, C Hutton, A Infantino, F Lavorini… - The Journal of Allergy …, 2017 - Elsevier
Background Poor inhaler technique has been linked to poor asthma outcomes. Training can
reduce the number of inhaler errors, but it is unknown which errors have the greatest impact …
reduce the number of inhaler errors, but it is unknown which errors have the greatest impact …
[HTML][HTML] Retail sales of inhalation devices in European countries: so much for a global policy
… Federico Lavorini has been reimbursed for attending conferences and/or giving talks by,
and acted as consultant for Menarini Industrie Farmaceutiche, AstraZeneca, Chiesi …
and acted as consultant for Menarini Industrie Farmaceutiche, AstraZeneca, Chiesi …
New inhaler devices-the good, the bad and the ugly
F Lavorini, GA Fontana, OS Usmani - Respiration, 2014 - karger.com
Drug delivery to the lungs is an effective way of targeting inhaled therapeutic aerosols and
treating obstructive airway diseases, such as asthma and chronic obstructive pulmonary …
treating obstructive airway diseases, such as asthma and chronic obstructive pulmonary …
Defective motor control of coughing in Parkinson's disease
GA Fontana, T Pantaleo, F Lavorini… - American journal of …, 1998 - atsjournals.org
The high incidence of serious chest infections in patients with Parkinson's disease is
unexplained, but an impairment in cough reflex may have a role. Maximal voluntary cough (MVC) …
unexplained, but an impairment in cough reflex may have a role. Maximal voluntary cough (MVC) …
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study
…, F Verrillo, A Bartoloni, R Marcucci, F Lavorini… - European Journal of …, 2022 - Elsevier
Objective: To investigate the persistence of symptoms compatible with COVID-19 in a real-file
prospective cohort of patients at 12 months from hospital discharge. Methods: Longitudinal…
prospective cohort of patients at 12 months from hospital discharge. Methods: Longitudinal…
[HTML][HTML] Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab
The current pandemic emergence of novel coronavirus disease (COVID-19) poses a relevant
threat to global health. SARS-CoV-2 infection is characterized by a wide range of clinical …
threat to global health. SARS-CoV-2 infection is characterized by a wide range of clinical …